Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Patel NR, Cunoosamy DM, Fagerås M, Taib Z, Asimus S, Hegelund-Myrbäck T, Lundin S, Pardali K, Kurian N, Ersdal E, Kristensson C, Korsback K, Palmér R, Brown MN, Greenaway S, Siew L, Clarke GW, Rennard SI, Make BJ, Wise RA, Jansson P. Patel NR, et al. Among authors: fageras m. Int J Chron Obstruct Pulmon Dis. 2018 Mar 27;13:1009-1019. doi: 10.2147/COPD.S150576. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 29628759 Free PMC article. Clinical Trial.
Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD.
Calverley PM, Eriksson G, Jenkins CR, Anzueto AR, Make BJ, Persson A, Fagerås M, Postma DS. Calverley PM, et al. Among authors: fageras m. Int J Chron Obstruct Pulmon Dis. 2016 Dec 19;12:13-25. doi: 10.2147/COPD.S114209. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 28031707 Free PMC article. Clinical Trial.
A novel endpoint for exacerbations in asthma to accelerate clinical development: a post-hoc analysis of randomised controlled trials.
Fuhlbrigge AL, Bengtsson T, Peterson S, Jauhiainen A, Eriksson G, Da Silva CA, Johnson A, Sethi T, Locantore N, Tal-Singer R, Fagerås M. Fuhlbrigge AL, et al. Among authors: fageras m. Lancet Respir Med. 2017 Jul;5(7):577-590. doi: 10.1016/S2213-2600(17)30218-7. Epub 2017 Jun 2. Lancet Respir Med. 2017. PMID: 28583396 Clinical Trial.
At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.
Martinez FJ, Han MK, Allinson JP, Barr RG, Boucher RC, Calverley PMA, Celli BR, Christenson SA, Crystal RG, Fagerås M, Freeman CM, Groenke L, Hoffman EA, Kesimer M, Kostikas K, Paine R 3rd, Rafii S, Rennard SI, Segal LN, Shaykhiev R, Stevenson C, Tal-Singer R, Vestbo J, Woodruff PG, Curtis JL, Wedzicha JA. Martinez FJ, et al. Among authors: fageras m. Am J Respir Crit Care Med. 2018 Jun 15;197(12):1540-1551. doi: 10.1164/rccm.201710-2028PP. Am J Respir Crit Care Med. 2018. PMID: 29406779 Free PMC article. No abstract available.
Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.
Müllerová H, Dransfield MT, Thomashow B, Jones PW, Rennard S, Karlsson N, Fageras M, Metzdorf N, Petruzzelli S, Rommes J, Sciurba FC, Tabberer M, Merrill D, Tal-Singer R. Müllerová H, et al. Among authors: fageras m. Am J Respir Crit Care Med. 2020 May 1;201(9):1058-1067. doi: 10.1164/rccm.201907-1369PP. Am J Respir Crit Care Med. 2020. PMID: 31815521 Free PMC article. No abstract available.
Objectively Measured Physical Activity as a COPD Clinical Trial Outcome.
Burtin C, Mohan D, Troosters T, Watz H, Hopkinson NS, Garcia-Aymerich J, Moy ML, Vogiatzis I, Rossiter HB, Singh S, Merrill DD, Hamilton A, Rennard SI, Fageras M, Petruzzelli S, Tal-Singer R, Tomaszewski E, Corriol-Rohou S, Rochester CL, Sciurba FC, Casaburi R, Man WD, Van Lummel RC, Cooper CB, Demeyer H, Spruit MA, Vaes A; CBQC Task Force on Physical Activity. Burtin C, et al. Among authors: fageras m. Chest. 2021 Dec;160(6):2080-2100. doi: 10.1016/j.chest.2021.06.044. Epub 2021 Jul 1. Chest. 2021. PMID: 34217679 Review.
33 results